Egyptian Board Infectious Diseases - independent subject foundations key terms

A laboratory measure of antimicrobial inhibition interpreted with the organism, method, breakpoint and achievable exposure rather than as an isolated outcome guarantee.

An enzyme class using a metal-dependent mechanism that differs from serine beta-lactamases and affects inhibitor selection.

An exposure-effect relationship used in appropriate drug assessment, with interpretation dependent on the class, organism and clinical setting.

An intervention addressing the anatomical or device-related focus of infection, which can be necessary alongside antimicrobial treatment.

Presence of an organism without sufficient evidence that it is causing the clinical infection being assessed.

Introduction of material that does not represent the intended clinical target, potentially affecting diagnostic interpretation.

A standardized reporting framework whose purpose and thresholds can differ from an individual bedside diagnostic assessment.

A summary of tested isolate susceptibility in a defined population and period, not an individual patient's complete microbiological result.

Reassessment toward a more targeted effective regimen when the relevant clinical and microbiological evidence permits.

Coordinated work to improve appropriate drug use, balancing effective treatment with safety and ecological consequences.

Infection-related life-threatening organ dysfunction interpreted through an appropriate clinical and consensus framework rather than fever alone.

A microbial community-associated growth state that can affect device infection and the interpretation of treatment and source-control options.

An infection whose occurrence or severity is influenced by impaired host defense in the actual clinical context.

An inflammatory deterioration associated with recovering immune responses that requires assessment of infection and competing causes.

A disease assessment involving relevant organ evidence rather than treating every isolated viral-load result as proof of tissue invasion.

A fungal-associated antigen test whose contribution depends on the host, specimen, assay performance and complete diagnostic context.

Evidence of mycobacterial infection without established active disease after the appropriate assessment, with preventive-treatment decisions made separately.

The measured presence or burden of parasites in blood, interpreted with species, host and the actual severity framework.

A dormant liver-stage form relevant to relapse from certain malaria species and to an eligible radical-cure strategy.

Evaluation of an erythrocyte enzyme relevant to the safety of selected oxidant medicines, with method and timing affecting interpretation.